At MedSense, our research is dedicated to advancing healthcare innovations at the nanoscale, with a multidisciplinary focus across four core domains: Sensors, Bioimaging Probes, Therapy & Theranostics, and Nanopore Technology. Our work in sensors involves developing diagnostic platforms for biomarker detection, artificial enzymes, and tools for environmental safety such as explosive detection. In the field of bioimaging probes, we specialize in designing molecular tools for subcellular targeting, disease progression monitoring, organelle tracking, and staining applications. Our therapy & theranostics efforts are directed toward creating innovative solutions for photodynamic and photothermal therapies, alongside developing anticancer agents and antimicrobials. Meanwhile, our work in nanopore technology enables single-molecule sensing, DNA gating, soft material analysis, and single-cell investigations. Collectively, these research areas underscore our commitment to translational nanomedicine and precision diagnostics for improved human health.
May, 2025
ACS Appl. Bio Mater. 2025, 8, 6,
4779–4790
Multifunctional Tradescantia pallida Derived Copper−Nitrogen Codoped Green Carbon Dots as Nanozyme, Dual Sensor, and Fluorescent Ink for Anticounterfeiting and Smart Textiles
2025